Oral Session 2-14D Post-transplant Complications/Graft Failure/Endothelial Injury

[OS2-14D-1] Impact of pre-transplant donor-specific anti-HLA antibodies in cord blood transplantation

Shigeo Fuji¹, Kumi Oshima², Kazuteru Ohashi³, Masashi Sawa⁴, Takeshi Saito⁵, Tetsuya Eto⁶, Masatsugu Tanaka⁷, Makoto Onizuka⁸, Hirohisa Nakamae⁹, Souichi Shiratori¹⁰, Yukiyasu Ozawa¹¹, Michihiro Hidaka¹², Tokiko Nagamura¹³, Hidenori Tanaka¹⁴, Takahiro Fukuda¹⁵, Tatsuo Ichinohe¹⁶, Yoshiko Atsuta¹⁷, Masao Ogata¹⁸ (1.Osaka International Cancer Institute, Osaka, Japan, 2.Jyoban Hospital, Fukushima, Japan, 3.Komagome Hospital, Tokyo, Japan, 4.Anjo Kosei Hospital, Aichi, Japan, 5.Jikei University School of Medicine, Tokyo, Japan, 6.Hamanomachi Hospital, Fukuoka, Japan, 7.Kanagawa Cancer Center, Kanagawa, Japan, 8.Tokai University School of Medicine, Kanagawa, Japan, 9.Osaka City University Hospital, Osaka, Japan, 10.Hokkaido University Hospital, Hokkaido, Japan, 11.Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 12.National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 13.Institute of Medical Science, University of Tokyo, Tokyo, Japan, 14.HLA laboratory, Kyoto, Japan, 15.National Cancer Center Hospital, Tokyo, Japan, 16.Hiroshima University, Hiroshima, Japan, 17.Japanese Data Center for Hematopoietic Cell Transplantation, 18.Oita University Hospital, Oita, Japan)